Erratum: Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden (Allergy and Asthma Proceedings (2014) 35, (185-190) DOI:10.2500/aap.2014.35.3738);Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden

Allergy and Asthma Proceedings

Volumn 35, Issue 2, 2014, Pages 185-190

  Nordenfelt, Patrik ^a,b   Dawson, Simon ^c   Wahlgren, Carl Fredrik ^d   Lindfors, Anders ^d   Mallbris, Lotus ^d   Bjor̈kander, Janne ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c ViroPharma Europe   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ASSESSMENT; DISEASE REGISTRY; DISEASE SEVERITY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LEAVE; QUALITY OF LIFE; SWEDEN; ADOLESCENT; ADULT; AGED; ANGIOEDEMAS, HEREDITARY; CHILD; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; PERCEPTION; PRESCHOOL CHILD; PSYCHOLOGY; QUESTIONNAIRE; REGISTER; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMAS, HEREDITARY; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; RETROSPECTIVE STUDIES; SWEDEN; YOUNG ADULT;

EID: 84897037871     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.1917     Document Type: Erratum

References (19)

1. Bygum A. Hereditary angio-oedema in Denmark: A nationwide survey. Br J Dermatol 161:1153-1158, 2009.
2. Roche O, Blanch A, Caballero T, et al. Hereditary angioedema due to C1 inhibitor deficiency: Patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 94:498-503, 2005. (Pubitemid 40547939)
3. Bork K, Meng G, Staubach P, et al. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 119:267-274, 2006. (Pubitemid 43255068)
4. Bork K, Staubach P, Eckardt AJ, and Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 101:619-627, 2006. (Pubitemid 43340941)
5. Lumry WR, Castaldo AJ, Vernon MK, et al. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407-414, 2010.
6. Bernstein JA. HAE update: Epidemiology and burden of disease. Allergy Asthma Proc 34:3-6, 2013.
7. Bygum A, Aygören-Pursun E, Caballero T, et al. The hereditary angioedema burden of illness study in Europe (HAE-BOISEurope): Background and methodology. BMC Dermatol 12:4, 2012.
8. Caballero T, Aygören-Pursun E, Bygum A, et al. The humanistic burden of hereditary angioedema: Results from the Burden of Illness Study in Europe. Allergy Asthma Proc 2013. (Epub ahead of print November 13, 2013.)
9. Mallbris L, Nordenfelt P, Björkander J, et al. The establishment and utility of Sweha-Reg: A Swedish population-based registry to understand hereditary angioedema. BMC Dermatol 7:6, 2007.
10. Harrison MJ, Lunt M, Verstappen SM, et al. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health Qual Life Outcomes 8:21, 2010.
11. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727-1736, 2011.
12. Allegra L, Cremonesi G, Girbino G, et al. Real-life prospective study on asthma control in Italy: Cross-sectional phase results. Respir Med 106:205-214, 2012.
13. Stafford MR, Hareendran A, Ng-Mak DS, et al. EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs. Health Qual Life Outcomes 10:65, 2012.
14. Craig T, Aygören-Pürsün EA, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5:182-199, 2012.
15. Cicardi M, Bork K, Caballero T, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group. Allergy 67:147-157, 2012.
16. Craig T, Riedl M, Dykewicz MS, et al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 102:366-372, 2009.
17. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6:24, 2010.
18. Kind P, Dolan P, Gudex C, et al. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ 316:736-741, 1998. (Pubitemid 28121072)
19. Caballero T, Farkas H, Bouillet L, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 129:308-320, 2012.